Literature DB >> 21881266

A new hypoxia inducible factor-2 inhibitory pyrrolinone alkaloid from roots and stems of Piper sarmentosum.

Heidi Rose Bokesch1, Roberta Scott Gardella, Daniel Christopher Rabe, Donald Paul Bottaro, William Marston Linehan, James Brislin McMahon, Tawnya Carlene McKee.   

Abstract

A new trimethoxycinnamoyl-2-pyrrolinone alkaloid, langkamide (1), along with the known compounds piplartine (2) and 3,4,5-trimethoxycinnamic acid (3) were isolated from the roots and stems of the shrub Piper sarmentosum ROXB. The structures were established by spectroscopic analyses and comparison of their spectral data with values reported in the literature. The compounds were tested for their ability to modulate hypoxia inducible factor-2 (HIF-2) transcription activity and all three showed HIF-2 inhibitory activity with EC₅₀ values of 14.0, 4.8, and 60.6 μM, respectively, for compounds 1, 2, and 3.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21881266      PMCID: PMC3166232          DOI: 10.1248/cpb.59.1178

Source DB:  PubMed          Journal:  Chem Pharm Bull (Tokyo)        ISSN: 0009-2363            Impact factor:   1.645


  11 in total

1.  Cytotoxic pyridone alkaloids from the leaves of Piper aborescens.

Authors:  C Y Duh; Y C Wu; S K Wang
Journal:  J Nat Prod       Date:  1990 Nov-Dec       Impact factor: 4.050

Review 2.  Identification of the genes for kidney cancer: opportunity for disease-specific targeted therapeutics.

Authors:  W Marston Linehan; Peter A Pinto; Ramaprasad Srinivasan; Maria Merino; Peter Choyke; Lynda Choyke; Jonathan Coleman; Jorge Toro; Gladys Glenn; Cathy Vocke; Bert Zbar; Laura S Schmidt; Donald Bottaro; Len Neckers
Journal:  Clin Cancer Res       Date:  2007-01-15       Impact factor: 12.531

3.  Role of hypoxia-inducible factor (HIF)-1alpha versus HIF-2alpha in the regulation of HIF target genes in response to hypoxia, insulin-like growth factor-I, or loss of von Hippel-Lindau function: implications for targeting the HIF pathway.

Authors:  Veronica A Carroll; Margaret Ashcroft
Journal:  Cancer Res       Date:  2006-06-15       Impact factor: 12.701

Review 4.  Hypoxia inducible factor-2alpha in cancer.

Authors:  Tobias Löfstedt; Erik Fredlund; Linda Holmquist-Mengelbier; Alexander Pietras; Marie Ovenberger; Lorenz Poellinger; Sven Påhlman
Journal:  Cell Cycle       Date:  2007-04-13       Impact factor: 4.534

5.  Antifungal amides from Piper arboreum and Piper tuberculatum.

Authors:  Renata Vasques da Silva; Hosana M Debonsi Navickiene; Massuo J Kato; Vanderlan da S Bolzani; Christiane I Méda; Maria Claudia M Young; Maysa Furlan
Journal:  Phytochemistry       Date:  2002-03       Impact factor: 4.072

6.  Siamenol, a new carbazole alkaloid from Murraya siamensis.

Authors:  K M Meragelman; T C McKee; M R Boyd
Journal:  J Nat Prod       Date:  2000-03       Impact factor: 4.050

7.  Effect of radiation and ibuprofen on normoxic renal carcinoma cells overexpressing hypoxia-inducible factors by loss of von Hippel-Lindau tumor suppressor gene function.

Authors:  Sanjeewani T Palayoor; Melissa A Burgos; Azadeh Shoaibi; Philip J Tofilon; C Norman Coleman
Journal:  Clin Cancer Res       Date:  2004-06-15       Impact factor: 12.531

Review 8.  Targeting hypoxia cell signaling for cancer therapy.

Authors:  Giovanni Melillo
Journal:  Cancer Metastasis Rev       Date:  2007-06       Impact factor: 9.264

9.  Neovastat (AE-941) inhibits the airway inflammation via VEGF and HIF-2 alpha suppression.

Authors:  Sook Young Lee; Su-Mi Chung
Journal:  Vascul Pharmacol       Date:  2007-09-18       Impact factor: 5.773

10.  High throughput extraction of plant, marine and fungal specimens for preservation of biologically active molecules.

Authors:  Thomas G McCloud
Journal:  Molecules       Date:  2010-06-24       Impact factor: 4.411

View more
  8 in total

1.  New strategies in renal cell carcinoma: targeting the genetic and metabolic basis of disease.

Authors:  Ramaprasad Srinivasan; Christopher J Ricketts; Carole Sourbier; W Marston Linehan
Journal:  Clin Cancer Res       Date:  2015-01-01       Impact factor: 12.531

2.  Piperlongumine inhibits proliferation and survival of Burkitt lymphoma in vitro.

Authors:  Seong-Su Han; Dong-Ju Son; Hwakyung Yun; Natalie L Kamberos; Siegfried Janz
Journal:  Leuk Res       Date:  2012-12-10       Impact factor: 3.156

3.  Endothelial PAS domain protein 1 activates the inflammatory response in the intestinal epithelium to promote colitis in mice.

Authors:  Xiang Xue; Sadeesh Ramakrishnan; Erik Anderson; Matthew Taylor; Ellen M Zimmermann; Jason R Spence; Sha Huang; Joel K Greenson; Yatrik M Shah
Journal:  Gastroenterology       Date:  2013-07-13       Impact factor: 22.682

Review 4.  The VHL/HIF axis in clear cell renal carcinoma.

Authors:  Chuan Shen; William G Kaelin
Journal:  Semin Cancer Biol       Date:  2012-06-13       Impact factor: 15.707

Review 5.  VHL, the story of a tumour suppressor gene.

Authors:  Lucy Gossage; Tim Eisen; Eamonn R Maher
Journal:  Nat Rev Cancer       Date:  2015-01       Impact factor: 60.716

6.  Biological and physical approaches on the role of piplartine (piperlongumine) in cancer.

Authors:  Tiago Henrique; Caroline de F Zanon; Ana P Girol; Ana Carolina Buzzo Stefanini; Nayara S de A Contessoto; Nelson J F da Silveira; Daniel P Bezerra; Edilberto R Silveira; José M Barbosa-Filho; Marinonio L Cornélio; Sonia M Oliani; Eloiza H Tajara
Journal:  Sci Rep       Date:  2020-12-17       Impact factor: 4.379

7.  Effects of Piper sarmentosum Roxb. on hypertension and diabetes mellitus: A systematic review and meta-analysis.

Authors:  Nur Syakirah Othman; Nur Aishah Che Roos; Amilia Aminuddin; Jaya Kumar Murthy; Adila A Hamid; Azizah Ugusman
Journal:  Front Pharmacol       Date:  2022-08-25       Impact factor: 5.988

Review 8.  ABC transporters in CSCs membranes as a novel target for treating tumor relapse.

Authors:  Laura Zinzi; Marialessandra Contino; Mariangela Cantore; Elena Capparelli; Marcello Leopoldo; Nicola A Colabufo
Journal:  Front Pharmacol       Date:  2014-07-10       Impact factor: 5.810

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.